Delirium screening in the neurointensive care unit: Comparison of the confusion assessment method for the intensive care unit and intensive care delirium screening checklist
Hannah Breit , Nicholas G. Panos , Kristen Fisher , Amy Blackwood , Christine Yeager , Mica Schachter , George Michalopoulos , Luke G. Petry , Ivan Da Silva , Sayona John
{"title":"Delirium screening in the neurointensive care unit: Comparison of the confusion assessment method for the intensive care unit and intensive care delirium screening checklist","authors":"Hannah Breit , Nicholas G. Panos , Kristen Fisher , Amy Blackwood , Christine Yeager , Mica Schachter , George Michalopoulos , Luke G. Petry , Ivan Da Silva , Sayona John","doi":"10.1016/j.jns.2025.123619","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Delirium is a common and serious potential complication of an ICU stay, associated with risk of mortality and worse outcomes. Screening tools including ICDSC and CAM-ICU have been validated in critical care populations, however, few studies have examined their utility in neurocritically ill patients. Research on delirium is highly segregated with varying terminology used among specialties, making research efforts difficult.</div></div><div><h3>Objectives</h3><div>Evaluate which screening tool is more feasible in neurocritically ill patients.</div></div><div><h3>Methods</h3><div>Single-center, retrospective analysis of a prospective QI initiative in a neurosciences ICU at a tertiary medical center in Chicago, IL. Patients admitted January 2019–2020 were screened for delirium with ICDSC, CAM-ICU and “gold-standard” DSM-5 throughout ICU stay. 206 patients were included who underwent 1442 assessments. Agreement of detection tools assessed using Fleiss' kappa.</div></div><div><h3>Results</h3><div>Prevalence of delirium using DSM-5 criteria was 1.6 %. Of the 1442 assessments, 116 were CAM-ICU-positive (8 %) and 343 were ICDSC-positive (23.8 %). The three tools had a kappa-agreement of 0.249. Of the 23 patients with confirmed delirium per DSM-5, 10 (4.8 %) were also positive for ICDSC but negative for CAM-ICU. 7 patients with a positive DSM-5 diagnosis were negative for both the CAM-ICU and ICDSC. CAM-ICU: sensitivity 26 %, specificity 94.5 %. ICDSC: sensitivity 69.5 %, specificity 87.6 %.</div></div><div><h3>Conclusions</h3><div>Current methods for detection of delirium in the neurocritically ill are imperfect, and terminology bias exists in the literature, limiting data comparison. While limited, the ICDSC appears a more sensitive tool for detection of delirium in the neurocritically ill compared to CAM-ICU. Larger validation studies are warranted.</div></div>","PeriodicalId":17417,"journal":{"name":"Journal of the Neurological Sciences","volume":"476 ","pages":"Article 123619"},"PeriodicalIF":3.2000,"publicationDate":"2025-07-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of the Neurological Sciences","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0022510X25002369","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background
Delirium is a common and serious potential complication of an ICU stay, associated with risk of mortality and worse outcomes. Screening tools including ICDSC and CAM-ICU have been validated in critical care populations, however, few studies have examined their utility in neurocritically ill patients. Research on delirium is highly segregated with varying terminology used among specialties, making research efforts difficult.
Objectives
Evaluate which screening tool is more feasible in neurocritically ill patients.
Methods
Single-center, retrospective analysis of a prospective QI initiative in a neurosciences ICU at a tertiary medical center in Chicago, IL. Patients admitted January 2019–2020 were screened for delirium with ICDSC, CAM-ICU and “gold-standard” DSM-5 throughout ICU stay. 206 patients were included who underwent 1442 assessments. Agreement of detection tools assessed using Fleiss' kappa.
Results
Prevalence of delirium using DSM-5 criteria was 1.6 %. Of the 1442 assessments, 116 were CAM-ICU-positive (8 %) and 343 were ICDSC-positive (23.8 %). The three tools had a kappa-agreement of 0.249. Of the 23 patients with confirmed delirium per DSM-5, 10 (4.8 %) were also positive for ICDSC but negative for CAM-ICU. 7 patients with a positive DSM-5 diagnosis were negative for both the CAM-ICU and ICDSC. CAM-ICU: sensitivity 26 %, specificity 94.5 %. ICDSC: sensitivity 69.5 %, specificity 87.6 %.
Conclusions
Current methods for detection of delirium in the neurocritically ill are imperfect, and terminology bias exists in the literature, limiting data comparison. While limited, the ICDSC appears a more sensitive tool for detection of delirium in the neurocritically ill compared to CAM-ICU. Larger validation studies are warranted.
期刊介绍:
The Journal of the Neurological Sciences provides a medium for the prompt publication of original articles in neurology and neuroscience from around the world. JNS places special emphasis on articles that: 1) provide guidance to clinicians around the world (Best Practices, Global Neurology); 2) report cutting-edge science related to neurology (Basic and Translational Sciences); 3) educate readers about relevant and practical clinical outcomes in neurology (Outcomes Research); and 4) summarize or editorialize the current state of the literature (Reviews, Commentaries, and Editorials).
JNS accepts most types of manuscripts for consideration including original research papers, short communications, reviews, book reviews, letters to the Editor, opinions and editorials. Topics considered will be from neurology-related fields that are of interest to practicing physicians around the world. Examples include neuromuscular diseases, demyelination, atrophies, dementia, neoplasms, infections, epilepsies, disturbances of consciousness, stroke and cerebral circulation, growth and development, plasticity and intermediary metabolism.